TCM
PRAH

Teza Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Teza Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,265
Closed -$423K – 784
2019
Q3 		$423K Buy
+4,265
New +$424K 0.11% 301

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Teza Capital Management's PRAH Position: Q4 2019 in Review

Teza Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2019, closing a stake of 4,265 shares — an estimated $423K sold.

Teza Capital Management first reported a position in PRAH in Q3 2019 and held it in 1 quarter. The position peaked at $423K in Q3 2019. 345 funds tracked by Wall St. Rank hold PRAH as of Q4 2019.

  • Teza Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q4 2019 after selling out during the quarter.
  • Teza Capital Management sold 4,265 PRA Health Sciences, Inc. shares in Q4 2019, an estimated $423K.
  • Teza Capital Management first reported a position in PRA Health Sciences, Inc. in Q3 2019 and held it in 1 quarter.
  • Teza Capital Management's PRA Health Sciences, Inc. position peaked at $423K in Q3 2019.
  • 345 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2019.

Based on Teza Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.